Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Lannett Company Inc is a drug manufacturers-specialty & generic business based in the US. Lannett Company shares (LCI) are listed on the NYSE and all prices are listed in US Dollars. Lannett Company employs 564 staff and has a trailing 12-month revenue of around $340.6 million.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Active traders
| Latest market close | $0.48 |
|---|---|
| 52-week range | $0.43 - $3.20 |
| 50-day moving average | $0.55 |
| 200-day moving average | $0.85 |
| Wall St. target price | $1.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-7.89 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.48 from 2022-09-26
| 1 week (2022-09-21) | -10.95% |
|---|---|
| 1 month (2022-08-26) | -10.78% |
| 3 months (2022-06-28) | -18.64% |
| 6 months (2022-03-25) | -40.15% |
| 1 year (2021-09-28) | -84.86% |
|---|---|
| 2 years (2020-09-28) | -91.85% |
| 3 years (2019-09-27) | 11.08 |
| 5 years (2017-09-27) | 19.25 |
| Revenue TTM | $340.6 million |
|---|---|
| Gross profit TTM | $46.1 million |
| Return on assets TTM | -7.51% |
| Return on equity TTM | -18622.01% |
| Profit margin | -68.01% |
| Book value | $3.14 |
| Market capitalisation | $20.6 million |
TTM: trailing 12 months
We're not expecting Lannett Company to pay a dividend over the next 12 months.
Lannett Company's shares were split on a 3:2 basis on 2 March 2003. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Lannett Company shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Lannett Company shares which in turn could have impacted Lannett Company's share price.
Over the last 12 months, Lannett Company's shares have ranged in value from as little as $0.43 up to $3.2. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Lannett Company's is 0.9948. This would suggest that Lannett Company's shares are less volatile than average (for this exchange).
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's product portfolio includes Amphetamine IR tablets, Amphetamine ER capsules, Dicyclomine tablets, Fluphenazine tablets, Levothyroxine capsules, Methylphenidate CD capsules, Methylphenidate ER, Posaconazole DR tablets, Probenecid tablets, and Verapamil SR tablets, as well as Numbrino nasal solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, Sinotherapeutics, Respirent Pharmaceuticals Co.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.